Top 10 Companies in the (2S, 5S)-5-Hydroxypipecolic Acid Market (2026): Market Leaders Driving Global Research

MARKET INSIGHTS

Global (2S, 5S)-5-Hydroxypipecolic Acid market size was valued at USD 18.6 million in 2025. The market is projected to grow from USD 20.1 million in 2026 to USD 38.4 million by 2034, exhibiting a CAGR of 7.4% during the forecast period.

(2S, 5S)-5-Hydroxypipecolic Acid is a naturally occurring hydroxylated derivative of pipecolic acid, a non-proteinogenic amino acid found in various biological systems. This compound, characterized by its specific stereochemical configuration at the 2S and 5S positions, plays a notable role in plant immunity signaling pathways and has garnered significant interest in pharmaceutical and biochemical research for its structural and functional properties.

The market is witnessing steady growth driven by increasing research activity in plant defense mechanisms, expanding applications in drug discovery, and rising demand for high-purity specialty amino acid derivatives in academic and industrial laboratories. Furthermore, growing investments in natural product chemistry and the broadening scope of asymmetric synthesis techniques are supporting the commercial availability and adoption of this compound across research institutions and pharmaceutical companies worldwide.

(2S, 5S)-5-Hydroxypipecolic Acid Market – View in Detailed Research Report

---

🔟 1. MilliporeSigma (Sigma‑Aldrich)

Headquarters: Irving, Texas, USA / Darmstadt, Germany
Key Offering: Research‑grade (2S, 5S)-5‑Hydroxypipecolic Acid, custom synthesis, chiral purification services

MilliporeSigma leverages its extensive chiral chemistry infrastructure to provide enantiopure hydroxypipecolic acid derivatives for academic and pharmaceutical R&D. The company’s robust quality assurance program ensures consistent stereochemical integrity, essential for drug discovery and natural product synthesis.

Sustainability Initiatives:

• Investments in green chemistry protocols to reduce solvent usage and waste generation.
• Partnerships with academic institutions to develop low‑energy synthesis routes.
• Commitment to ISO 14001 environmental management standards across manufacturing sites.

---

🔹 9. TCI Chemicals

Headquarters: Tokyo, Japan
Key Offering: Catalog listing of (2S, 5S)-5‑Hydroxypipecolic Acid, custom synthesis, analytical services

TCI Chemicals provides high‑purity chiral amino acids for medicinal chemistry and peptide research. Their state‑of‑the‑art asymmetric synthesis platform allows rapid scale‑up of the (2S, 5S) isomer for industrial and academic clients.

Sustainability Initiatives:

• Implementation of renewable energy sources in production facilities.
• Optimization of catalyst recycling processes to lower environmental footprint.
• Collaboration with universities to promote sustainable synthetic methodologies.

---

🔸 8. Combi‑Blocks

Headquarters: San Diego, USA
Key Offering: Modular peptide building blocks including (2S, 5S)-5‑Hydroxypipecolic Acid, custom peptide synthesis services

Combi‑Blocks specializes in providing bespoke amino acid derivatives for peptide therapeutics. Their rapid custom synthesis capability supports accelerated discovery cycles for oncology and neurodegenerative disease programs.

Sustainability Initiatives:

• Use of biodegradable resins and recyclable Fmoc protecting groups.
• Energy‑efficient flow‑chemistry platforms for reduced carbon footprint.
• Participation in the Pharmaceutical Industry’s Green Chemistry Challenge.

---

🔵 7. AstaTech Inc.

Headquarters: San Francisco, USA / Shanghai, China
Key Offering: Custom synthesis of (2S, 5S)-5‑Hydroxypipecolic Acid, analytical validation, supply of protected derivatives

AstaTech’s integrated synthesis‑analysis platform delivers high‑purity chiral amino acids to pharmaceutical R&D labs worldwide. The company’s expertise in chiral resolution supports efficient production of the (2S, 5S) configuration.

Sustainability Initiatives:

• Adoption of solvent‑free reaction conditions where feasible.
• Partnerships with NGOs to promote green chemistry education.
• Continuous improvement of waste‑to‑energy conversion in production plants.

---

🟢 6. Ark Pharm

Headquarters: New York, USA / Shanghai, China
Key Offering: Research‑grade (2S, 5S)-5‑Hydroxypipecolic Acid, bulk production, chiral synthesis kits

Ark Pharm focuses on providing cost‑effective, high‑purity chiral amino acids for academic and industrial users. Their scalable synthetic routes enable rapid response to increasing demand for specialized intermediates.

Sustainability Initiatives:

• Implementation of closed‑loop solvent recovery systems.
• Use of renewable feedstocks for chiral catalyst synthesis.
• Engagement with regulatory bodies to advance green chemistry standards.

---

🟠 5. Shanghai Yuanye Bio‑Technology Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Bulk (2S, 5S)-5‑Hydroxypipecolic Acid, custom synthesis, analytical support

Shanghai Yuanye provides high‑quality chiral amino acids to the Chinese and global research markets. Their integrated platform supports rapid scale‑up for both academic and pharmaceutical customers.

Sustainability Initiatives:

• Adoption of green solvents and reduced‑energy synthesis protocols.
• Investment in waste‑minimization technologies.
• Collaboration with local universities on sustainable chemistry research.

---

🔴 4. Fluorochem Ltd.

Headquarters: Oxford, United Kingdom
Key Offering: Specialty chiral reagents, (2S, 5S)-5‑Hydroxypipecolic Acid, custom synthesis services

Fluorochem delivers a portfolio of advanced chiral building blocks for pharmaceutical and academic research. Their expertise in fluorinated and hydroxylated amino acids supports innovative drug design.

Sustainability Initiatives:

• Use of renewable energy sources in manufacturing facilities.
• Development of eco‑friendly protecting groups.
• Participation in the UK’s Green Chemistry Initiative.

---

🟡 3. Watanabe Chemical Industries, Ltd.

Headquarters: Tokyo, Japan
Key Offering: Chiral amino acid derivatives, (2S, 5S)-5‑Hydroxypipecolic Acid, custom synthesis, analytical validation

Watanabe’s long‑standing expertise in chiral chemistry positions it as a preferred supplier for research institutions and pharmaceutical developers seeking high‑purity intermediates.

Sustainability Initiatives:

• Implementation of energy‑efficient manufacturing processes.
• Use of biodegradable solvents and recyclable materials.
• Collaboration with governmental agencies to promote green chemistry policies.

---

⚫ 2. Thermo Fisher Scientific

Headquarters: Waltham, Massachusetts, USA
Key Offering: Comprehensive catalog of chiral amino acids, including (2S, 5S)-5‑Hydroxypipecolic Acid, custom synthesis, analytical services

Thermo Fisher’s global distribution network and advanced analytical capabilities support researchers worldwide in accessing high‑quality chiral intermediates for drug discovery and natural product synthesis.

Sustainability Initiatives:

• Commitment to 100% renewable electricity at manufacturing sites by 2030.
• Development of low‑toxicity, solvent‑free synthetic routes.
• Partnerships with academic institutions to promote sustainable chemistry.

---

⚪ 1. Cayman Chemical

Headquarters: Ann Arbor, Michigan, USA
Key Offering: Research‑grade (2S, 5S)-5‑Hydroxypipecolic Acid, custom synthesis, analytical support

Cayman Chemical provides a wide range of chiral reagents and amino acids for academic and industrial research. Their focus on high‑purity products ensures reliable performance in sensitive assays and drug development.

Sustainability Initiatives:

• Implementation of closed‑loop waste management systems.
• Use of renewable feedstocks for chiral catalysts.
• Participation in the Sustainable Chemistry Initiative.

---

Download FREE Sample Report: (2S, 5S)-5-Hydroxypipecolic Acid Market – View in Detailed Research Report

---

Get Full Report: (2S, 5S)-5-Hydroxypipecolic Acid Market – View in Detailed Research Report

---

🌍 Outlook: The Future of (2S, 5S)-5-Hydroxypipecolic Acid Market

The (2S, 5S)-5‑Hydroxypipecolic Acid market is poised for continued expansion driven by emerging therapeutic applications, advances in biocatalysis, and increasing demand for chiral building blocks in peptide therapeutics. Key factors shaping the future include:

• Growth in drug discovery pipelines focused on constrained peptides and peptidomimetics.
• Expansion of automated solid‑phase peptide synthesis (SPPS) and flow‑chemistry platforms.
• Advancements in enzymatic hydroxylation enabling cost‑effective production of the (2S, 5S) isomer.
• Strategic collaborations between fine‑chemical manufacturers and academic research institutions.
• Regulatory support for high‑purity chiral intermediates in drug development.

---

📈 Key Trends Shaping the Market:

• Increasing investments in natural product chemistry and asymmetric synthesis techniques.
• Broadening scope of biocatalytic platforms for stereoselective hydroxylation.
• Rising focus on plant immunity signaling pathways as a source of novel therapeutics.
• Enhanced demand for high‑purity specialty amino acid derivatives in pharmaceutical R&D.
• Adoption of green chemistry practices across the supply chain.